Masayuki Nakamori

Assistant Professor

Osaka University

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (17)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (9)

Kazuhiko Nakatani

Professor

Osaka University

JAPAN

View details

Hiroshi Shimizu

Associate Professor

Niigata University

JAPAN

View details

Maria Spies

UNITED STATES

View details

Krzysztof Jagla

FRANCE

View details

Naoki Suzuki

Tohoku University

JAPAN

View details

Arturo López Castel

Assistant Professor

University of Valencia

SPAIN

View details

Joe Nemoto

Yamaguchi University

JAPAN

View details

Carla-Marie Jurkovic

CANADA

View details

Hideaki Nishihara

Assistant Professor

Yamaguchi University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Masayuki Nakamori

Research Interests

Explore related searches

Contact this professor

Articles (17)

Establishment of a novel amyotrophic lateral sclerosis patient (TARDBPN345K/+)-derived brain microvascular endothelial cell model reveals defective Wnt/β-catenin signaling: investigating diffusion barrier dysfunction and immune cell interaction.

Contribution of Complement, Microangiopathy and Inflammation in Idiopathic Inflammatory Myopathies.

Efficacy confirmation study of aceneuramic acid administration for GNE myopathy in Japan.

Deregulations of miR-1 and its target Multiplexin promote dilated cardiomyopathy associated with myotonic dystrophy type 1.

Phase II/III Study of Aceneuramic Acid Administration for GNE Myopathy in Japan.

Antagonistic roles of canonical and Alternative-RPA in disease-associated tandem CAG repeat instability

Erythromycin for myotonic dystrophy type 1: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.

Intracerebral Distribution of CAG Repeat-Binding Small Molecule Visualized by Whole-Brain Imaging.

Antineutrophil cytoplasmic antibody-associated vasculitis with predominant truncal muscle weakness: a retrospective case series.

Analysis of splicing abnormalities in the white matter of myotonic dystrophy type 1 brain using RNA sequencing.

Expanded‐repeat‐RNA‐mediated disease mechanisms in myotonic dystrophy

Therapeutic approach for myotonic dystrophy: Recent advances in translational research

Pharmacotherapy alleviates pathological changes in human direct reprogrammed neuronal cell model of myotonic dystrophy type 1.

Cell type-specific abnormalities of central nervous system in myotonic dystrophy type 1.

Expanded CUG Repeat RNA Induces Premature Senescence in Myotonic Dystrophy Model Cells.

Cellular Senescence and Aging in Myotonic Dystrophy.

CAG repeat-binding small molecule improves motor coordination impairment in a mouse model of Dentatorubral-pallidoluysian atrophy.

Collaborators (9)

Kazuhiko Nakatani

Hiroshi Shimizu

Maria Spies

Krzysztof Jagla

Naoki Suzuki

Arturo López Castel

Joe Nemoto

Carla-Marie Jurkovic

Hideaki Nishihara

Make your next move.